| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BMS-708163 | GDSC1000 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | 0.039 | 0.4 |
| mRNA | selumetinib:decitabine (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.4 |
| mRNA | JW-74 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.4 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |